Related content

Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia

By  

Current Alzheimer Research, Vol. 15, Iss. 4, 2018-02 ,pp. : 386-398

Bentham Science Publishers

Access to resources Recommend Favorite

The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE ε4 allele increases the risk of late-onset Alzheimer disease

By Wang Binbin   Jin Feng   Yang Ze   Lu Zeping   Kan Rui   Li Shu   Zheng Chenguang   Wang Li  

Journal of Molecular Neuroscience, Vol. 30, Iss. 3, 2006-10 ,pp. : 267-271

Humana Press, Inc

Access to resources Recommend Favorite

A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease

By Tian J.   Shi J.   Bailey K.   Harris J.M.   Pritchard A.   Lambert J.-C.   Chartier-Harlin M.-C.   Pickering-Brown S.M.   Lendon C.L.   Mann D.M.A.  

Neuroscience Letters, Vol. 354, Iss. 2, 2004-01 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite

Use of angiotensin-converting enzyme inhibitors for Alzheimer’s disease: an update

By O’Caoimh Rónán   Kehoe Patrick Gavin   Kennedy Paul   Molloy William  

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 511-514

Future Medicine

Access to resources Recommend Favorite

Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer’s disease and vascular dementia

By Wang H. K.   Fung H. C.   Hsu W. C.   Wu Y. R.   Lin J. C.   Ro L. S.   Chang K. H.   Hwu F. J.   Hsu Y.   Huang S. Y.   Lee-Chen G. J.   Chen C. M.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1499-1509

Springer Publishing Company

Access to resources Recommend Favorite